Intermittent Nitric Oxide Combined with Intravenous Dipyridamole in a Piglet Model of Acute Pulmonary Hypertension

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Anesthesia and Analgesia

• Publication date

  2003-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1213/01.ANE.0000082529.68736.04PMID 14570673
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhalation of 0.30 ppm nitrogen dioxide potentiates exercise-induced bronchospasm in asthmatics.

  2015cited by this paper
• Intravenous Dipyridamole Enhances the Effects of Inhaled Nitric Oxide and Prevents Rebound Pulmonary Hypertension in Piglets

  2002cited by this paper
• Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension.

  2002cited by this paper
• Sildenafil Is a Pulmonary Vasodilator in Awake Lambs with Acute Pulmonary Hypertension

  2000cited by this paper
• Dipyridamole potentiates pulmonary vasodilation induced by acetylcholine and nitric oxide in the ovine fetus.

  1998cited by this paper
• Pulmonary toxicity associated with nitric oxide in term infants with severe respiratory failure.

  1998cited by this paper
• Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension.

  1998cited by this paper
• The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide.

  1995cited by this paper
• Prolonged pulmonary vasodilator action of inhaled nitric oxide by Zaprinast in awake lambs.

  1995influential reference
• Dipyridamole, a cGMP phosphodiesterase inhibitor, causes pulmonary vasodilation in the ovine fetus.

  1995cited by this paper
• Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: dose response.

  1994cited by this paper
• Safety guidelines for use of nitric oxide.

  1992cited by this paper
• Interaction of nitrogen dioxide with human plasma Antioxidant depletion and oxidative damage

  1992cited by this paper
• Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.

  1990cited by this paper
• Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta.

  1986cited by this paper
• Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations.

  1977cited by this paper

• Arterial pulmonary hypertension in noncardiac intensive care unit

  2008cites this paper
• Transitions and Combination Therapy for Pulmonary Arterial Hypertension

  2008cites this paper
• Prostanoids and phosphodiesterase inhibitors in experimental pulmonary hypertension.

  2005cites this paper